Bristol Myers Squibb (BMY) EV to EBITDA (2009 - 2026)
Bristol Myers Squibb's (BMY) EV to EBITDA was 8.15 for Q3 2026, up 40.0% from 5.82 a year earlier and up 15.3% from the prior quarter.
Bristol Myers Squibb (BMY) EV to EBITDA (2009 - 2026) Analysis & Trends
Over the twelve months ended Sep 30, 2026, Bristol Myers Squibb's EV to EBITDA came in at 5.87, up 94.1% year-over-year; for FY2025, it came in at 7.44, down 91.3% from FY2024.
- By year, EV to EBITDA came in at 85.15 in FY2024, 5.03 in FY2023 (-36.2%), 7.88 in FY2022 (+24.4%) and 6.34 in FY2021 (-82.0%).
- Five-year quarterly EV to EBITDA spans a low of 5.03 in Q4 2023 and a high of 85.15 in Q4 2024.
- Year over year, EV to EBITDA has now increased in each of the last three quarters, with an average decline of 35.4% over the last seven quarters.
- The high point for year-over-year EV to EBITDA in five years was Q3 2024 (growth of 389.6%); the low point was Q4 2025 (a decline of 91.3%).
- Per Business Quant data, the three quarters before Q3 2026 came in at 7.07 (Q2 2026), 8.60 (Q1 2026) and 7.44 (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,276.89 Bn | 1,250.50 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 681.31 Bn | 601.18 Bn | 17.30 Bn |
| 3 | AbbVie | 520.63 Bn | 488.64 Bn | 13.12 Bn |
| 4 | Merck | 357.22 Bn | 320.16 Bn | 13.19 Bn |
| 5 | Novartis Ag | 310.90 Bn | 284.14 Bn | - |
| 6 | Astrazeneca | 285.12 Bn | 258.77 Bn | 13.26 Bn |
| 7 | Amgen | 250.23 Bn | 201.89 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 207.56 Bn | 182.67 Bn | 6.73 Bn |
| 9 | Pfizer | 164.42 Bn | 111.77 Bn | 12.56 Bn |
| 10 | Bristol Myers Squibb | 128.63 Bn | 83.82 Bn | 8.92 Bn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 8.15 |
| Jun 30, 2026 | 7.07 |
| Mar 31, 2026 | 8.60 |
| Dec 31, 2025 | 7.44 |
| Sep 30, 2025 | 5.82 |
| Jun 30, 2025 | 6.16 |
| Mar 31, 2025 | 7.92 |
| Dec 31, 2024 | 85.15 |
| Sep 30, 2024 | 29.33 |
| Jun 30, 2024 | 21.51 |
| Mar 31, 2024 | 24.97 |
| Dec 31, 2023 | 5.03 |
| Sep 30, 2023 | 5.99 |
| Jun 30, 2023 | 6.69 |
| Mar 31, 2023 | 7.21 |
| Dec 31, 2022 | 7.88 |
| Sep 30, 2022 | 7.88 |
| Jun 30, 2022 | 8.34 |
| Mar 31, 2022 | 7.87 |
| Dec 31, 2021 | 6.34 |
Bristol Myers Squibb EV to EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=BMY&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-ebitda", "ticker": "BMY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=BMY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();